Â鶹´«Ã½

Skip to main content

Refine your results

Filters

Displaying 61 - 80 of 168

Advocacy Filings

FTC Staff Comment to The Honorable John J. Bonacic Concerning New York S.B. 3186-A, To Allow Health Care Providers to Negotiate Collectively With Health Plans

Date
Matter Number
V110015
Related Release
FTC Staff Says Proposed New York Legislation Likely to Lead to Higher Health Care Costs and Decreased Access to Health Care Services for Consumers
Advocacy Filings

FTC Staff Letter to the Honorable Gary Odom, Tennessee House of Representatives, Concerning Tennessee House Bill 1896 (H.B. 1896) and the Regulation of Providers of Interventional Pain Management Services

Date
Matter Number
V110011
Related Release
FTC Staff: Proposed Tennessee Legislation May Reduce Patient Access to Pain Management Services and Increase Prices
Advocacy Filings

FTC Staff Comment to the Honorable James L. Seward, Concerning New York Assembly Bill 5502-B to Regulate the Use of Mail Order Pharmacies by Health Plans Offering Prescription Drug Coverage

Date
Matter Number
V110013
Related Release
FTC Staff Says Proposed New York Legislation Would Reduce Competition and Likely Lead to Higher Prescription Drug Costs
Advocacy Filings

FTC Staff Comment to Senators Coleman and Kissel and Representatives Fox and Hetherington Concerning Connecticut H.B. 6343, Intended To Exempt Members of Certified Cooperative Arrangements From the Antitrust Laws

Date
Matter Number
V110012
Related Release
FTC Staff Says Proposed Connecticut Legislation Would Likely Increase Health Care Costs and Decrease Access to Care
Advocacy Filings

FTC Staff Letter To The Honorable Rodney Ellis and The Honorable Royce West, The Senate of the State of Texas, Concerning Texas Senate Bills 1260 and 1339 and the Regulation of Advanced Practice Registered Nurses

Date
Matter Number
V110007
Related Release
FTC Staff: Proposed Texas Legislation Likely Would Benefit Health Care Consumers; Would Allow Expanded Patient Care by Advanced Practice Registered Nurses
Advocacy Filings

FTC Staff Comment to the Hon. Elliot Naishtat Concerning Texas S.B. 8 to Exempt Certified Health Care Collaboratives From the Antitrust Laws

Date
Matter Number
V110009
Related Release
FTC Staff: Proposed Texas Legislation Likely to Lead to Dramatically Increased Costs and Decreased Access to Health Care for Texas Consumers
Advocacy Filings

FTC Staff Letter to the Honorable Mark Formby, Mississippi House of Representatives, Concerning Mississippi Senate Bill 2445 and the Regulation of Pharmacy Benefit Managers

Date
Matter Number
V110005
Â鶹´«Ã½ Trade Commission Statement Concerning Reliance on Prior PBM-Related Adv…
Related Release
FTC Staff: Mississippi Bill That Would Give State Pharmacy Board Authority Over PBMs Likely to Increase Prescription Drug Costs and Reduce Competition
FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy
Advocacy Filings

FTC Staff Comment Before the Alabama State Board of Medical Examiners Concerning the Proposed Regulation of Interventional Pain Management Services

Date
Matter Number
V110000
Related Release
FTC Staff: Proposed Alabama Rule Would Likely Limit the Availability and Increase Cost of Pain Management Services for Alabama Consumers
Advocacy Filings

FTC Staff Comment Before the Kentucky Cabinet for Health and Family Services Concerning Proposed Rule to Regulate Limited Service Clinics

Date
Matter Number
V100007
Related Release
Commission Approves FY 2011 Budget Request and GPRA Performance Plans for Submission to Congress; FTC Staff: Proposed Kentucky Regulations for Licensing Retail Clinics Raise Competitive Concerns; FTC Issues Annual Financial Acts Â鶹´«Ã½ Report to
Advocacy Filings

FTC Comment Before the Department of Health and Human Services Concerning the Policy and Technical Changes to the Medicare Advantage and the Medicare Prescription Drug Benefit Programs

Date
Matter Number
V100003
Related Release
FTC Submits Comment to HHS on Providing Consumers Better Information About Medicare Advantage and Prescription Drug Plans
Advocacy Filings

FTC Staff Comment to the Honorable James L. Seward Concerning New York Senate Bill 58 on Pharmacy Benefit Managers (PBMs)

Date
Matter Number
V090006
Â鶹´«Ã½ Trade Commission Statement Concerning Reliance on Prior PBM-Related Adv…
Related Release
FTC Staff Comment Says New York Bill to Regulate Pharmacy Benefit Managers May Increase Pharmaceutical Prices for New York Consumers; Commission Approves Final Consent Order in Matter of Dow Chemical Company and Rohm & Haas Company
FTC Votes to Issue Statement Withdrawing Prior Pharmacy Benefit Manager Advocacy
Advocacy Filings

FTC Staff Comment to Representative Tom Emmer of the Minnesota House of Representatives Concerning Minnesota ok H.F. No. 120 and Senate Bill S.F. No. 203 on Health Care Cooperatives

Date
Matter Number
V090003
Related Release
FTC Staff Comment Says Bills to Authorize Collective Bargaining by Minnesota Health Care Cooperatives will Raise Health Care Costs for Minnesota Consumers
Advocacy Filings

FTC and Department of Justice Written Testimony Before the Illinois Task Force on Health Planning Reform Concerning Illinois Certificate of Need Laws

Date
Matter Number
V080018
Related Release
Â鶹´«Ã½ Trade Commission, Department of Justice Issue Joint Statement on Certificate-of-Need Laws in Illinois
Advocacy Filings

FTC Staff Comment to the Hon. William J. Seitz Concerning Ohio Executive Order 2007-23S to Establish Collective Bargaining for Home Health Care Workers

Date
Matter Number
V080001
Related Release
FTC Staff Submits Comments on Establishing Collective Bargaining for Independent Home Care Providers in Ohio
Advocacy Filings

FTC Staff Comment Before the Puerto Rico House of Representatives Concerning S.B. 2190 to Permit Collective Bargaining by Health Care Providers

Date
Matter Number
V080003
Related Release
Commission Staff Files Comments with Puerto Ricos Treasury and Financial Affairs Commission on Health Care Collective Bargaining Bill

Displaying 61 - 80 of 168

Return to top